These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 639856)

  • 1. Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1978 Apr; 48(3):281-95. PubMed ID: 639856
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of peripheral and local administration of picrotoxin on the release of newly synthesized 3H-dopamine in the caudate nucleus of the cat.
    Cheramy A; Nieoullon A; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):31-7. PubMed ID: 870831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
    Olianas MC; De Montis GM; Mulas G; Tagliamonte A
    Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat.
    Gundlach AL; Beart PM
    J Pharm Pharmacol; 1981 Jan; 33(1):41-3. PubMed ID: 6114152
    [No Abstract]   [Full Text] [Related]  

  • 5. GABA in the caudate nucleus: a possible synaptic transmitter of interneurons.
    Spehlmann R; Norcross K; Grimmer EJ
    Experientia; 1977 May; 33(5):623-5. PubMed ID: 193718
    [No Abstract]   [Full Text] [Related]  

  • 6. gamma-Aminobutyric acid: the essential mediator of behaviour triggered by neostriatally applied apomorphine and haloperidol.
    Cools AR; Janssen HJ
    J Pharm Pharmacol; 1976 Jan; 28(1):70-4. PubMed ID: 6658
    [No Abstract]   [Full Text] [Related]  

  • 7. Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Science; 1977 Oct; 198(4315):416-8. PubMed ID: 910137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
    Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
    Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Jun; 148(1):143-52. PubMed ID: 656921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
    Javoy F; Euvrard C; Herbet A; Bockaert J; Enjalbert A; Agid Y; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):233-9. PubMed ID: 141623
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
    Racagni G; Bruno F; Cattabeni F; Maggi A; Di Giulio AM; Parenti M; Groppetti A
    Brain Res; 1977 Oct; 134(2):353-8. PubMed ID: 890495
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo evidence for GABAergic control of serotonin release in the cat substantia nigra.
    Soubrié P; Montsatruc JL; Bourgoin S; Reisine T; Artaud F; Glowinski J
    Eur J Pharmacol; 1981 Feb; 69(4):483-8. PubMed ID: 6166484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of cortico-striatal "glutamatergic" neurons in the presynaptic control of dopamine release in the cat caudate nucleus.
    Chéramy A; Barbeito L; Romo R; Godeheu G; Glowinski J
    Clin Neuropharmacol; 1986; 9 Suppl 4():500-2. PubMed ID: 3567956
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of unilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigrostriatal dopaminergic pathways.
    Chéramy A; Chesselet MF; Romo R; Leviel V; Glowinski J
    Neuroscience; 1983 Apr; 8(4):767-80. PubMed ID: 6866262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1992 Aug; 219(2):175-81. PubMed ID: 1330605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of various amino acids on the modulation of dopamine release from nigro-striatal dopaminergic neurones.
    Giorguieff-Chesselet MF; Besson MJ; Cheramy A; Glowinski J
    J Physiol (Paris); 1979; 75(6):611-3. PubMed ID: 547062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum.
    Starr MS
    Eur J Pharmacol; 1978 Apr; 48(3):325-8. PubMed ID: 639860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulating effects of gamma-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat.
    Chéramy A; Nieoullon A; Glowinski J
    J Pharmacol Exp Ther; 1977 Nov; 203(2):283-93. PubMed ID: 909063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.